Fresh news on health and wellness in Saint Vincent and the Grenadines

Provided by AGP

St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

Press releases published on May 14, 2026

20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
Biodexa issues letter to Shareholders
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Dogwood Therapeutics Announces First Quarter 2026 Financial Results
FDA Approves New Dosing Option for CRYSVITA® (burosumab-twza) in Adults With XLH
Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
CapeHaven Completes First Close of Funding and Initiates Operations to Encourage Yale’s Biotech Spinouts
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Responds to BBB Challenge with Next-Gen Drug-Delivery Platform
SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Developing Distinct Next-Gen GLP-1 Built Around Novel Peptide
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Harnesses Key AI, Voice Analysis to Offer Impairment Solution
Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine
Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8
OrganOx Announces Appointment of Naoya Iwata as CEO & President
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease
Koelis Announces ProMap® Smart Automatic Prostate Contouring Software at AUA 2026
Kyverna Therapeutics to Present at Upcoming Investor Conferences
Keros Therapeutics Reports Recent First Quarter 2026 Financial Results

Share us

on your social networks:

Sign up for:

St. Vincent & Grenadines Health Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.